Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis

INTRODUCTION: Risk of adverse effects and flare of inflammatory bowel disease (IBD) are frequently cited reasons for COVID-19 vaccine hesitancy. METHODS: Electronic databases were searched to identify studies reporting the use of COVID-19 vaccine in IBD. We selected studies reporting the incidence o...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Deepak, Jena, Anuraag, Bharath, Pardhu Neelam, Choudhury, Arup, Singh, Anupam K., Sebastian, Shaji, Sharma, Vishal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938236/
https://www.ncbi.nlm.nih.gov/pubmed/35382972
http://dx.doi.org/10.1016/j.dld.2022.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938236/
https://www.ncbi.nlm.nih.gov/pubmed/35382972
http://dx.doi.org/10.1016/j.dld.2022.03.005

Ejemplares similares